Clinical Trials on Lower Urinary Tract Disorder in Czechia

Total 903 results

Stimvia s.r.o.

Completed

Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

Overactive Bladder (OAB) | Failed Any OAB Pharmacotherapy

Czechia
Myopowers Medical Technologies France SAS

Completed

ARTUS MONO Artificial Urinary Sphincter

Urinary Incontinence,Stress

France, Czechia
University Hospital Olomouc
Palacky University

Recruiting

Effect of Beta-alanine and Pelvic Floor Muscle Training on Urinary Incontinence After Radical Prostatectomy (BELA) (BELA)

Urinary Incontinence | Prostate Cancer | Radical Prostatectomy | Pelvic Floor Muscle Training | Beta-Alanine

Czechia
Myopowers Medical Technologies France SAS
EVAMED; Affluent Medical

Not yet recruiting

Safety and Clinical Performance Study of the ARTUS® Artificial Urinary Sphincter (AUS) (DRY)

Stress Urinary Incontinence

Spain, Czechia
Vensica Therapeutics Ltd.

Completed

Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in Subjects With Idiopathic Overactive Bladder

Overactive Bladder

Czechia, Portugal
University Hospital Ostrava

Recruiting

Adjustable Artificial Sphincter Victo in the Treatment of Male Incontinence Due to Prostate Surgery

Urinary Incontinence

Czechia
GT Urological, LLC

Completed

Clinical Investigation of GT UrologIcal, LLC's Artificial Urinary Sphincter (RELIEF II) (RELIEFII)

Male Stress Urinary Incontinence

Australia, Czechia, New Zealand
University Hospital Ostrava

Recruiting

This Research Project Studies the Relationship Between OSA and Nocturia.

Obstructive Sleep Apnea

Czechia
University Hospital Ostrava

Completed

Electronic Method for Recording Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms

Czech Republic
Allergan

Completed

Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Overactive Bladder | Urinary Incontinence

Poland, United Kingdom, Belgium, Canada, Russian Federation, United States, Germany, Czechia
Allergan

Completed

A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

Overactive Bladder | Urinary Incontinence

Poland, United Kingdom, Germany, Canada, Belgium, United States, Czechia
University Hospital Ostrava

Recruiting

The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS Patients

Multiple Sclerosis | Lower Urinary Tract Symptoms

Czechia
University Hospital Ostrava

Recruiting

Fetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients

Arterial Hypertension

Czechia
Masaryk Memorial Cancer Institute
Masaryk University

Recruiting

Prostate Cancer Screening With Abbreviated MRI Protocol (ProstaPilot)

Prostate Cancer

Czechia
University Hospital Ostrava

Recruiting

Onset of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients

Multiple Sclerosis | Lower Urinary Tract Symptoms

Czechia
Sanofi

Completed

SSR240600C Treatment in Women With Overactive Bladder (BILADY)

Overactive Bladder

France, Germany, Netherlands, Portugal, Czech Republic, United States, Canada
National Institute of Mental Health, Czech Republic

Recruiting

Pregnancy Without Psychosocial Stress

Depression, Postpartum | Depressive Symptoms | Anxiety Disorders and Symptoms

Czechia
Allergan

Completed

Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Overactive Bladder

Poland, United Kingdom, Belgium, Russian Federation, Czech Republic, Germany, United States
National Institute of Mental Health, Czech Republic

Recruiting

Remote Peer Support in Prevention of Postpartum Depression

Postpartum Depression

Czechia
St. Anne's University Hospital Brno, Czech Republic

Completed

Influence of Different Anesthetic Procedures on Sleep Disorder Breathing

Obstructive Sleep Apnea

Czechia
Bayer

Completed

Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB) (OVADER)

Overactive Bladder

Austria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
University Hospital Ostrava

Completed

Bioelectrical Impedance in Monitoring Hyperhydration and Polyneuromyopathy in Critically Ill Patients

Septic Shock | Respiratory Insufficiency | Hypoxemia | Chronic Obstructive Pulmonary Disease Exacerbation | Lung Ventilator | Hyperhydration | Respiratory Distress Syndrome, Acute

Czechia
Czech Technical University in Prague

Unknown

Evaluation of Breathing Effort in Spontaneously Breathing Subjects

Healthy

Czechia
Ferring Pharmaceuticals

Completed

A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) (DELUTS)

Lower Urinary Tract Symptoms (LUTS)

United States, Canada, Belgium, Czech Republic, Italy, Poland
Allergan

Completed

A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Urinary Incontinence

United States, Belgium, Czechia, Canada, France, Italy, Poland, Turkey
Allergan

Completed

Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients

Urinary Incontinence

United States, Belgium, Canada, Poland, Italy, France, Czechia, Turkey
Astellas Pharma Europe B.V.

Completed

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder (Blossom)

Urinary Bladder, Overactive

Belgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
St. Anne's University Hospital Brno, Czech Republic
Masaryk University

Recruiting

OSA as a Remote Ischemic Preconditioning in Vascular Surgery

Obstructive Sleep Apnea | Ischemia Reperfusion Injury | Vascular Aneurysm

Czechia
RECORDATI GROUP

Completed

Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury

Neurogenic Detrusor Overactivity

Czechia, France, Poland, Portugal
European Association of Urology Research Foundation
Boston Scientific Corporation

Recruiting

Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD (VENUS)

Urologic Diseases | Lower Urinary Tract Symptoms | Urinary Incontinence | Urination Disorders | Urinary Incontinence, Stress

Belgium, France, Netherlands, Spain, Germany, United Kingdom, Czechia
European Association of Urology Research Foundation
Boston Scientific Corporation

Active, not recruiting

Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence (SATURN)

Urinary Incontinence, Stress

Netherlands, Spain, United Kingdom, Belgium, Germany, Finland, Norway, Czechia, Italy
Ferring Pharmaceuticals

Completed

A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults

Nocturia

United States, Belgium, Czechia, Hungary, Poland, Canada, Germany
Ipsen

Terminated

Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

Overactive Bladder

United Kingdom, Spain, Netherlands, Belgium, France, Germany, Czechia, Italy
Charles University, Czech Republic

Recruiting

Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents

Pneumonia | Cough | Asthma | Asthma in Children | Dyspnea | Recurrent Respiratory Tract Infections | Shortness of Breath | Wheezing | Mucus; Plug | Lower Respiratory Tract and Lung Infections | Chest Tightness

Czechia
Allergan

Completed

Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)

Multiple Sclerosis | Urinary Incontinence | Neurogenic Bladder

France, Poland, Portugal, Belgium, Canada, Russian Federation, Czechia, United States
Allergan

Terminated

OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)

Urinary Incontinence | Urinary Bladder | Overactive

United States, Australia, Belgium, Canada, Czechia, France, Germany, Italy, Netherlands, Norway, Poland, South Africa, United Kingdom
Brno University Hospital
St. Anne's University Hospital Brno, Czech Republic

Recruiting

The Diagnosis of Superinfections in Mechanically Ventilated Covid-19 Patients (SUPER-BAL)

COVID-19 Pneumonia | ARDS, Human | Superinfection

Czechia
Astellas Pharma Europe Ltd.

Completed

A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice (BELIEVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder Overactive

Czechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
Pfizer

Completed

Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

Prostatic Hyperplasia

Netherlands, Czech Republic, Slovakia
Ferring Pharmaceuticals

Completed

A Study of Minirin Melt in Patients With Nocturia

Nocturia

Czech Republic
Thomayer University Hospital
Czech Academy of Sciences

Recruiting

Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis

Acute Pyelonephritis | Complicated Urinary Tract Infection

Czechia
Pfizer

Completed

Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder

Overactive Bladder

Czech Republic, Slovakia, United Kingdom, Sweden, Norway, Lithuania
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics (VEST)

Urinary Bladder, Overactive

Czech Republic
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Overactive Bladder

United Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
University Hospital Ostrava

Completed

Recurrent Respiratory Papillomatosis and Extraesophageal Reflux

Recurrent Respiratory Papillomatosis | Extra Oesophageal Reflux | Laryngeal Cyst

Czechia
Astellas Pharma Inc

Completed

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (CAPRICORN)

Urinary Bladder, Overactive

United States, Hungary, Canada, Spain, Finland, Slovakia, Czechia, Sweden, Germany, Denmark, Norway
Astellas Pharma Europe Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. (BEYOND)

Urologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases

Greece, Ireland, Armenia, Austria, Belarus, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lebanon, Lithuania, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovaki... and more
Astellas Pharma Inc

Completed

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (SCORPIO)

Urinary Bladder, Overactive

Australia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
Ferring Pharmaceuticals

Completed

A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia

Nocturia

Czech Republic
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)

Overactive Bladder

Poland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation

Clinical Trials on Lower Urinary Tract Disorder in Czechia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations